This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Adhesion

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The leukocyte alongside the endothelial cell then adheres to it by means of a complex interaction between complementary adhesion molecules

  • within minutes, released histamine and thrombin stimulate the appearance of a molecule, P-selectin of the endothelial cell surface
  • later, interleukin-1 and tumour necrosis factor promote the production of another endothelial molecule, E-selectin
  • these molecules retard the movement of the marginating leukocyte but do not halt it completely
    • this can only occur with the expression of a second-wave of binding proteins. On the leukocyte, these are termed integrins. Their complementary molecules on the endothelium are intercellular adhesion molecules - ICAMs - and vascular adhesion molecules - PECAMs
    • co-factors such as calcium are also required.

Disorder within the adhesion molecule structure can lead to a failure of leukocytes to reach the region of inflammation - leukocyte adhesion deficiency(1).

Reference:

  • 1) Anderson, D.C., Springer, T.A. (1987). Leukocyte adhesion deficiency. An inherited defect in the Mac-1, LFA-1, p150,95 glycoproteins. Ann. Rev. Med. 38, 175.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.